Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.56 |
| ▸ | MEN1 | O00255 | 6/20 | 0.56 |
| ▸ | PGR | P06401 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24864731 | 0.89 | KMT2A (0.65) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL30171504 | 0.85 | KMT2A (0.61) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL27212350 | 0.85 | KMT2A (0.61) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL30804603 | 0.83 | ALDH1A1 (0.59) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL27212336 | 0.83 | ALDH1A1 (0.59) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL24865025 | 0.81 | KMT2A (0.59) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL24864976 | 0.80 | ALDH1A1 (0.72) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL30804578 | 0.80 | ALDH1A1 (0.72) | KMT2AMEN1PGRALDH1A1KDM4E | |
| Water SCHEMBL30804585 | 0.78 | ALDH1A1 (0.68) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL24864974 | 0.75 | KMT2A (0.66) | KMT2AMEN1PGRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2023282236-A1 | RARE EARTH COMPLEX | 東ソー株式会社 | 2023-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | KMT2A 3223/4885MEN1 140/4885PGR 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.